EpiVax Therapeutics, Inc.
Biotechnology company · Providence, Rhode Island, United States
EpiVax Therapeutics, Inc. is a biotechnology company headquartered in Providence, Rhode Island, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $369,881 sold in a notice filed in 2021.
EpiVax Therapeutics at a glance
What does EpiVax Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $369,881 sold (2021).
Frequently asked questions about EpiVax Therapeutics
Where is EpiVax Therapeutics headquartered?
EpiVax Therapeutics, Inc. is headquartered in Providence, Rhode Island, United States.
What does EpiVax Therapeutics do?
EpiVax Therapeutics, Inc. is a biotechnology company.
When was EpiVax Therapeutics founded?
The earliest incorporation on record for EpiVax Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- Prothera Biologics, Inc.Providence, Rhode Island, United States
- Plans4Care INCProvidence, Rhode Island, United States
- Vitae Industries, IncProvidence, Rhode Island, United States
- Epivax, Inc.Providence, Rhode Island, United States
- Bolden Therapeutics, Inc.Providence, Rhode Island, United States
- Sention, Inc.Providence, Rhode Island, United States
- Lucidicor Inc.Providence, Rhode Island, United States
- Epigenter, LLCProvidence, Rhode Island, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences